Evidence map›Paper›PMID 40079171›Full record

ArticleStem cells and development2025

Effects of Complex I Inhibition on the Architecture of Neural Rosettes Differentiated from Human-Induced Pluripotent Stem Cells.

Stephanie Santarriaga, Magdalena Vater, Petra Dujmic, Kaia Gerlovin, Chun Wing Lee, Rakesh Karmacharya

Abstract read
In one paragraph

Article in Stem cells and development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stephanie SantarriagaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Magdalena VaterCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Petra DujmicCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kaia GerlovinCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Chun Wing LeeCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Rakesh KarmacharyaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-0565-5482

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2000 to 2019
$31.4M
A Nikon A1R Confocal Microscope SystemS10RR031563 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2011 to 2011
$561k
NCRR NIH HHS S10 RR031563NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521
6 · The paper itself

Abstract

Orchestrated changes in cell arrangements and cell-to-cell contacts are susceptible to cellular stressors during central nervous system development. Effects of mitochondrial complex I inhibition on cell-to-cell contacts have been studied in vascular and intestinal structures; however, its effects on developing neuronal cells are largely unknown. We investigated the effects of the classical mitochondrial stressor and complex I inhibitor, rotenone, on the architecture of neural rosettes-radially organized neuronal progenitor cells (NPCs)-differentiated from human-induced pluripotent stem cells. We then analyzed the effects of rotenone on the distribution of cell-contact proteins within neural rosettes. Exposure to rotenone for 24 hours led to a dose-dependent irreversible disruption of the neural rosette architecture and relocalization of the cell-contact proteins ZO-1, β-catenin, and N-cadherin from the rosette center to the pericellular region. Though the levels of nestin and SOX2 remained unchanged, NPCs showed decreased levels of the NPC marker PAX6 and exhibited impaired neurogenesis following rotenone exposure. Our study suggests that complex I inhibition leads to a rearrangement of intercellular contacts with disruptive effects on neuronal development.

Indexed as

Cell DifferentiationElectron Transport Complex IInduced Pluripotent Stem CellsNeural Stem CellsRotenonebeta CateninCadherinsEye ProteinsHomeodomain ProteinsHumansNestinNeurogenesisNeuronsPAX6 Transcription FactorRepressor ProteinsSOXB1 Transcription Factorsbeta CateninCadherinsCTNNB1 protein, humanElectron Transport Complex IEye ProteinsHomeodomain ProteinsNestinPAX6 protein, humanPAX6 Transcription FactorRepressor ProteinsRotenoneSOX2 protein, humanSOXB1 Transcription FactorsTJP1 protein, humanZonula Occludens-1 ProteiniPSCjunctional proteinsneurodevelopmentNPCoxidative stressrotenone

Identifiers

PMID40079171
PMCPMC12021791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.